Owkin vs Regard

Owkin is an AI biotechnology company that uses multimodal patient data to advance drug discovery, diagnostics, and precision medicine. Its federated learning platform enables healthcare institutions and pharmaceutical companies to collaborate on research while preserving patient privacy. Owkin combines clinical, imaging, genomic, and molecular data to identify biomarkers and predict treatment outcomes. The company partners with leading health systems and biopharma organizations to develop AI-powered therapeutics and companion diagnostics. Its solutions support oncology, immunology, and rare disease research.

Regard is an AI-powered clinical insights platform designed to help healthcare providers identify diagnoses and generate more complete clinical documentation. The platform analyzes patient records and surfaces relevant clinical findings at the point of care. It helps clinicians improve documentation accuracy, reduce administrative burden, and capture missed diagnoses. Regard reviews large amounts of patient data to provide actionable recommendations before and during patient visits. The platform is used by hospitals and health systems to improve care quality and operational performance. Its primary focus is proactive clinical decision support and documentation enhancement.